Search Results | Cancer Research | American Association for Cancer Research

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Abstract 1385: The influence of MHC class I and II on T cell responses in mouse melanoma

Amy K. Erbe, Arika Feils, Mackenzie Heck, Sabrina VandenHeuvel, Julianna Castillo, Alina Hampton, Lizzie Frankel, Anna Hoefges, Peter Carlson, Alex A. Pieper, Taylor Aiken, Lauren Zebertavage, David Komjathy, Dan Spiegelman, Noah Tsarovsky, Zachary S. Morris, Ravi Patel, Alexander Rakhmilevich, Paul M. Sondel

Cancer Res (2022) 82 (12_Supplement): 1385.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1385

Published: 15 June 2022

View article

Journal Articles

Abstract 1377: Endogenous antibodies recognize multiple proteins on B78 melanoma in mice cured via immunotherapy

Anna Hoefges, Sean J. McIlwain, Amy K. Erbe, Trang Q. Le, Kaitlin Tetreault, Nicholas Mathers, Alexander L. Rakhmilevich, Jacquelyn A. Hank, Jigar Patel, Brad Garcia, Zachary S. Morris, Irene M. Ong, Paul M. Sondel

Cancer Res (2022) 82 (12_Supplement): 1377.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1377

Published: 15 June 2022

View article

Journal Articles

Abstract 2019: Tumor-targeting and efficacy of B7H3/GD2 bispecific SNIPER antibodies

Amy K. Erbe, Arika Feils, Zack Rosenkrans, Jessica Wiwczar, Daniel Gerhardt, Bonnie Hammer, Mildred Felder, Mark Bercher, Alina Hampton, Lizzie Frankel, Dan Spiegelman, Noah Tsarovsky, Alexander Rakhmilevich, Jacquelyn Hank, Bryan Glaser, Reinier Hernandez, Roland Green, Paul M. Sondel

Cancer Res (2022) 82 (12_Supplement): 2019.

DOI: https://doi.org/10.1158/1538-7445.AM2022-2019

Published: 15 June 2022

View article

Journal Articles

Abstract 4455: Combination of bempegaldesleukin and anti-CTLA-4 prevents metastatic dissemination after primary surgery or radiation therapy in a preclinical model of non-small cell lung cancer

Ryan J. Brown, Luke Zangl, Ian Arthur, Alex Pieper, Peter M. Carlson, Juliana Castillo, Paul M. Sondel, Alexander Rakhmilevich, Zach S. Morris, Ravi B. Patel

Cancer Res (2020) 80 (16_Supplement): 4455.

DOI: https://doi.org/10.1158/1538-7445.AM2020-4455

Published: 15 August 2020

View article

Journal Articles

Abstract 902: Augmentation of anti-melanoma response by combining radiation-based in situ vaccination with GIFT4 B cell therapy

Elizabeth G. Sumiec, Claire C. Baniel, Amber M. Bates, Sarah Emma, Erin Nystuen, Alexander L. Rakhmilevich, Amy K. Erbe, Pradyut Paul, Jacques Galipeau, Paul M. Sondel, Zachary S. Morris

Cancer Res (2020) 80 (16_Supplement): 902.

DOI: https://doi.org/10.1158/1538-7445.AM2020-902

Published: 15 August 2020

View article

Journal Articles

Abstract 375: In vivo metabolic autofluorescence imaging of macrophage heterogeneity across normal and cancerous tissue

Tiffany Heaster, Karla Esbona, Paul M. Sondel, Melissa C. Skala

Cancer Res (2020) 80 (16_Supplement): 375.

DOI: https://doi.org/10.1158/1538-7445.AM2020-375

Published: 15 August 2020

View article

Journal Articles

Abstract IA10: Activating innate and adaptive immunity to improve outcome for “cold” tumors

Paul M. Sondel

Cancer Res (2020) 80 (14_Supplement): IA10.

DOI: https://doi.org/10.1158/1538-7445.PEDCA19-IA10

Published: 15 July 2020

View article

Journal Articles

Abstract LB-300: Natural antibodies to non-human glycans Neu5Gc and alpha-gal correlate with outcome of high-risk neuroblastoma patients treated with dinutuximab on COG ANBL0032 and ANBL0931

Mitchell B. Diccianni, Jenna Mielke, Richard Williams, Karen Messer, Fevzi Ozkaynak, Andrew L. Gilman, Arlene Naranjo, Wendy London, Paul M. Sondel, Julie Park, Alice L. Yu, Childrens Oncology Group

Cancer Res (2018) 78 (13_Supplement): LB-300.

DOI: https://doi.org/10.1158/1538-7445.AM2018-LB-300

Published: 01 July 2018

View article

Journal Articles

Abstract 4160: A new orotopically applied vasoconstrictor drug significantly confers normal oral mucosa resistance to radio-damage

Amanda Graul-Conroy, Margo Hoover-Regan, Paul M. Sondel, Natalie S. Callander, Walter L. Longo, Ningfeng F. Li, William E. Fahl

Cancer Res (2018) 78 (13_Supplement): 4160.

DOI: https://doi.org/10.1158/1538-7445.AM2018-4160

Published: 01 July 2018

View article

Journal Articles

Abstract LB-048: Impact of KIR/KIR ligand genotype for neuroblastoma patients in a Phase 3 COG immunotherapy trial

Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Patrick K. Reville, Wendy B. London, Jacquelyn A. Hank, Mitchell B. Diccianni, Arlene Naranjo, Michael Hogarty, Julie R. Park, Alice L. Yu, Paul M. Sondel

Cancer Res (2017) 77 (13_Supplement): LB-048.

DOI: https://doi.org/10.1158/1538-7445.AM2017-LB-048

Published: 01 July 2017

View article

Journal Articles

Abstract 4013: Transcriptionally mediated effects of radiation on the expression of immune susceptibility markers in murine and human melanoma

Lauryn R. Werner, Monica Gressett, Maureen Riegert, Shyhmin Huang, Joseph G. Kern, Amy Erbe, Paul M. Harari, Paul M. Sondel, Zachary S. Morris

Cancer Res (2016) 76 (14_Supplement): 4013.

DOI: https://doi.org/10.1158/1538-7445.AM2016-4013

Published: 15 July 2016

View article

Journal Articles

Abstract 4011: Effective in situ immunization via local radiation therapy (RT) and tumor-specific immunocytokine (IC): Suppression from distant tumor is blocked by RT or Treg-depleting CTLA-4 antibody

Zachary S. Morris, Emily Guy, David Francis, Monica M. Gressett, Eric A. Armstrong, Shyhmin Huang, Lauryn R. Werner, Stephen D. Gillies, Alan Korman, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Paul M. Harari, Paul M. Sondel

Cancer Res (2016) 76 (14_Supplement): 4011.

DOI: https://doi.org/10.1158/1538-7445.AM2016-4011

Published: 15 July 2016

View article

Journal Articles

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

Zachary S. Morris, Emily I. Guy, David M. Francis, Monica M. Gressett, Lauryn R. Werner, Lakeesha L. Carmichael, Richard K. Yang, Eric A. Armstrong, Shyhmin Huang, Fariba Navid, Stephen D. Gillies, Alan Korman, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Paul M. Harari, Paul M. Sondel

Cancer Res (2016) 76 (13): 3929–3941.

DOI: https://doi.org/10.1158/0008-5472.CAN-15-2644

Published: 30 June 2016

View article

Includes: Supplementary data

Journal Articles

Abstract 2538: Immune responses to common melanoma-associated antigens following intratumoral injection of alpha-gal glycolipids in patients with advanced melanoma

Cindy L. Zuleger, Paul M. Sondel, Jacquelyn A. Hank, Erik A. Ranheim, Thomas A. McFarland, Jennifer Collins, Erin Clements, Giles Whalen, Uri Galili, Mark R. Albertini

Cancer Res (2014) 74 (19_Supplement): 2538.

DOI: https://doi.org/10.1158/1538-7445.AM2014-2538

Published: 01 October 2014

View article

Journal Articles

Abstract 1538: Enhanced antitumor effects of intratumoral (IT) hu14.18-IL2 immunocytokine (IC) compared to intravenous (IV) hu14.18-IL2 are distinguished by increased activated tumor infiltrating lymphocytes (TILs) and IC retention

Richard K. Yang, Nicholas A. Kalogriopoulos, Alexander L. Rakhmilevich, Erik A. Ranheim, Songwon Seo, KyungMann Kim, Kory L. Alderson, Jacek Gan, Ralph A. Reisfeld, Stephen D. Gillies, Jacquelyn A. Hank, Paul M. Sondel

Cancer Res (2012) 72 (8_Supplement): 1538.

DOI: https://doi.org/10.1158/1538-7445.AM2012-1538

Published: 15 April 2012

View article

Journal Articles

Abstract 1809: Stimulation of antibody dependent cell-mediated cytotoxicity by interleukin-15 is equivalent to interleukin-2

Kimberly A. McDowell, Jacquelyn A. Hank, Paul M. Sondel

Cancer Res (2011) 71 (8_Supplement): 1809.

DOI: https://doi.org/10.1158/1538-7445.AM2011-1809

Published: 15 April 2011

View article

Journal Articles

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

David C. Delgado, Jacquelyn A. Hank, Jill Kolesar, David Lorentzen, Jacek Gan, Songwon Seo, KyungMann Kim, Suzanne Shusterman, Stephen D. Gillies, Ralph A. Reisfeld, Richard Yang, Brian Gadbaw, Kenneth B. DeSantes, Wendy B. London, Robert C. Seeger, John M. Maris, Paul M. Sondel

Cancer Res (2010) 70 (23): 9554–9561.

DOI: https://doi.org/10.1158/0008-5472.CAN-10-2211

Published: 06 December 2010

View article

Journal Articles

Abstract LB-195: Anti-CD40 and CpG-ODN enhance the antimelanoma response of hu14.18K322A in vivo.

Kory L. Alderson, Mitchell Luangrath, Stephen D. Gillies, Fariba Navid, Alexander L. Rakhmilevich, Paul M. Sondel

Cancer Res (2010) 70 (8_Supplement): LB-195.

DOI: https://doi.org/10.1158/1538-7445.AM10-LB-195

Published: 15 April 2010

View article

Journal Articles

Abstract LB-325: Antitumor effect of resveratrol combined with immunocytokine immunotherapy

Brenda L. Soto, Jacquelyn A. Hank, Arthur S. Polans, Tyler van de Voort, Alexander L. Rakhmilevich, Songwon Seo, Kim Kuyungmann, Stephen D. Gillies, Paul M. Sondel

Cancer Res (2010) 70 (8_Supplement): LB-325.

DOI: https://doi.org/10.1158/1538-7445.AM10-LB-325

Published: 15 April 2010

View article

Journal Articles

Nitric oxide and TNF-α are involved in the antitumor effects of anti-CD40 Ab-activated macrophages against murine melanoma

Hillary E. Lum, Ilia N. Buhtoiarov, Paul M. Sondel, Alexander L. Rakhmilevich

Cancer Res (2005) 65 (9_Supplement): 571.

Published: 01 May 2005

View article

NARROW

Abstract 1385: The influence of MHC class I and II on T cell responses in mouse melanoma

Abstract 1377: Endogenous antibodies recognize multiple proteins on B78 melanoma in mice cured via immunotherapy

Abstract 2019: Tumor-targeting and efficacy of B7H3/GD2 bispecific SNIPER antibodies

Abstract 4455: Combination of bempegaldesleukin and anti-CTLA-4 prevents metastatic dissemination after primary surgery or radiation therapy in a preclinical model of non-small cell lung cancer

Abstract 902: Augmentation of anti-melanoma response by combining radiation-based in situ vaccination with GIFT4 B cell therapy

Abstract 375: In vivo metabolic autofluorescence imaging of macrophage heterogeneity across normal and cancerous tissue

Abstract IA10: Activating innate and adaptive immunity to improve outcome for “cold” tumors

Abstract LB-300: Natural antibodies to non-human glycans Neu5Gc and alpha-gal correlate with outcome of high-risk neuroblastoma patients treated with dinutuximab on COG ANBL0032 and ANBL0931

Abstract 4160: A new orotopically applied vasoconstrictor drug significantly confers normal oral mucosa resistance to radio-damage

Abstract LB-048: Impact of KIR/KIR ligand genotype for neuroblastoma patients in a Phase 3 COG immunotherapy trial

Abstract 4013: Transcriptionally mediated effects of radiation on the expression of immune susceptibility markers in murine and human melanoma

Abstract 4011: Effective in situ immunization via local radiation therapy (RT) and tumor-specific immunocytokine (IC): Suppression from distant tumor is blocked by RT or Treg-depleting CTLA-4 antibody

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

Abstract 2538: Immune responses to common melanoma-associated antigens following intratumoral injection of alpha-gal glycolipids in patients with advanced melanoma

Abstract 1538: Enhanced antitumor effects of intratumoral (IT) hu14.18-IL2 immunocytokine (IC) compared to intravenous (IV) hu14.18-IL2 are distinguished by increased activated tumor infiltrating lymphocytes (TILs) and IC retention

Abstract 1809: Stimulation of antibody dependent cell-mediated cytotoxicity by interleukin-15 is equivalent to interleukin-2

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

Abstract LB-195: Anti-CD40 and CpG-ODN enhance the antimelanoma response of hu14.18K322A in vivo.

Abstract LB-325: Antitumor effect of resveratrol combined with immunocytokine immunotherapy

Nitric oxide and TNF-α are involved in the antitumor effects of anti-CD40 Ab-activated macrophages against murine melanoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only